Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which nerve block eases hip replacement pain better?

NCT ID NCT07017192

Symptom relief Sponsor: A.O.U. Città della Salute e della Scienza Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

This trial tests two regional anesthesia techniques for pain control after hip replacement surgery using the direct anterior approach. Half of the 50 participants receive a suprainguinal fascia iliaca (SIFI) block, and the other half receive a lumbar erector spinae plane (ESP) block. Researchers measure how well each block controls pain, reduces opioid use, and speeds up recovery of leg movement and hospital discharge.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Two regional anesthesia techniques: SIFI block and lumbar ESP block, both using ropivacaine injections.
What this could lead to
If one block proves better, it could lead to more effective pain control after hip replacement, faster recovery, and less reliance on opioids.
What could go wrong
This is a small, early-stage comparison, so results may not apply to all patients. Nerve blocks carry risks like infection or nerve damage, and either technique might not clearly outperform the other.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \>=18 years and =\<85 years * patients undergoing elective unilateral THA with direct anterior approach * patients able to understand the purposes of the study and provide signed informed consent Exclusion Criteria: * pregnancy * Age \<18 years or \>85 years * revision or bilateral surgeries * psychiatric pathology or cognitive deficits, mental retardation, inability to provide valid informed consent * History of illicit drugs and/or alcohol abuse * urgent/emergent surgery with admission to Intensive Care under sedation and mechanical ventilation or complications that do not allow evaluation * known allergy to the drugs used in the study * refusal to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip arthroplasty are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hip arthroplasty Hip pain Hip replacement postoperative Hip replacement surgery Hip replacement, total Hip surgery Mobility and independence Pain, postoperative

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AOU Città della Salute e della Scienza

    RECRUITING

    Torino, TO, 10126, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.